Zenlo
About Engine Database Cases
ds@zenlo.app Request a signatureRequest
Patterns
Structural · validation pending

Transparency · CHAI Applied Model Card

Hormonal Imbalance (Male)

CHAI Applied Model Card (v0.1) for the Hormonal Imbalance (Male) pattern in Zenlo Labs. This document is not CHAI-certified or CHAI-endorsed.

Header

Model nameHormonal Imbalance (Male)
DeveloperZenlo LLC
Release stageResearch Tool (not FDA-cleared)
Versionv0.1
AvailabilityUnited States
Regulatory statusNot applicable — academic and transparency positioning
Pattern slughormonal_male
BiomarkersTestosterone, Total, FREE_T, Cortisol, Cortisol (AM), DHEA-Sulfate

Summary

The Hormonal Imbalance (Male) pattern evaluates testosterone (total and free), cortisol, and DHEA-sulfate in adult male laboratory panels, flagging androgen deficiency, adrenal axis signals, or anabolic–catabolic imbalance for physician review. Deterministic rules apply sex-specific reference comparisons and pattern-specific abnormality thresholds. Claude Haiku 4.5 synthesizes narrative context on which hormonal markers contributed. For licensed functional-medicine physicians, this is supportive clinical decision support — it does not diagnose hypogonadism, adrenal insufficiency, or PCOS-equivalent conditions, and it does not guide hormone replacement dosing. Outputs highlight endocrine laboratory signals requiring correlation with symptoms, timing of collection, and repeat testing.

Uses & Directions

Intended use

Clinical decision support for licensed physicians reviewing male sex-hormone and adrenal marker patterns in adult panels.

Primary users

Licensed functional-medicine physicians and similarly qualified clinicians.

How to use

Review flagged hormones with diurnal collection timing, symptoms, medications, and repeat morning testosterone if indicated.

Target population

Adults aged 18 and older in the United States.

Out of scope

  • Direct patient use without physician oversight
  • Female or pediatric endocrine evaluation
  • Standalone diagnosis or hormone replacement prescribing
  • Dynamic stimulation or suppression testing interpretation

Warnings

Clinical risk level

Low — supportive tool; the treating physician retains full clinical judgment and responsibility.

Known limitations

  • Testosterone varies diurnally; single random samples may misclassify status.
  • Does not incorporate LH, FSH, SHBG, or prolactin in this pattern.
  • Cortisol interpretation depends heavily on collection time and stress context.

Validation note

Validation pending — a Tier A NHANES validation run has not yet been completed for this pattern. Distribution, agreement, and fairness results will be published here when available.

Trust Ingredients

AI system facts

  • Deterministic pattern detector (hormonal_male) plus Claude Haiku 4.5 for narrative synthesis
  • Primary inputs: Total testosterone, free testosterone, cortisol, and DHEA-sulfate from structured extraction.
  • Output: Pattern flag plus narrative on male hormonal marker abnormalities.

Security & compliance

  • Anthropic Business Associate Agreement with zero-data-retention configuration
  • HIPAA-aligned design; no patient data used for model training

Ongoing maintenance

Versioned, transparent, and reproducible via a public independent audit harness (see Resources).

Transparency

Self-funded development; no third-party sponsor for this pattern card.

Key Metrics

Usefulness / Efficacy

Zenlo’s detection approach was benchmarked across five models in a separate study; see the medRxiv preprint in Resources. No per-pattern efficacy metric is published for this pattern. Source: 5-model benchmark, medRxiv 10.64898/2026.02.13.26346284.

Fairness / Equity

Validation pending — a Tier A NHANES validation run has not yet been completed for this pattern. Distribution, agreement, and fairness results will be published here when available.

Safety / Reliability

  • Supportive-only; not intended as a standalone diagnostic
  • Physician authorization required before clinical use
  • Deterministic detector is reproducible for inputs: TESTO, FREE_T, CORTISOL, CORT, DHEAS

Resources

  • medRxiv preprint 10.64898/2026.02.13.26346284 — 5-model benchmark (system-level detector evaluation)
  • JAMIA Open submission JAMIO-2026-0120 (under review)
  • Independent audit harness: github.com/dimashibakov/zenlo-audit — reproducibility manifest, NHANES 2015–2016 cycle, harness commit c10afe8

Note: The mention or sharing of any examples, products, organizations, or individuals does not indicate any endorsement by the Coalition for Health AI (CHAI). Zenlo Labs is a clinical decision support tool intended exclusively for use by licensed healthcare providers — not a substitute for professional medical judgment, and not intended for direct patient use.

Version v0.1 · Zenlo Research

Zenlo
Terms· Privacy· Security· Contact· Cookie Notice
Biomarker Evidence Engine · © 2026 Zenlo LLCds@zenlo.app